Cynata Therapeutics Limited ( (AU:CYP) ) has issued an announcement. Cynata Therapeutics Limited announced it received a $1.7 million R&D Tax Incentive Refund for the 2024/2025 financial year. This ...

SEATTLE, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), today announced the appointment of Claudia Lopez, DVM, MSc, as its new Vice President, ...

Mesenchymal stem cells (MSCs) are adult stem cells that originate from the mesenchymal and connective tissue of the bone marrow, adipose tissue, placenta, umbilical cord, cord blood, peripheral blood, ...

Unlock the advantage of pragmatic trials and improve efficiency and real-world relevance to reduce risk and strengthen ...

Human mesenchymal stem cells (MSCs) hold great promise for clinical use and cell therapy applications. To ensure highest quality and safety of the resulting cellular products, MSCs have to be ...

This blended learning programme integrates academic knowledge and understanding of perfusion science with both the needs of the working professional clinical perfusion scientist and the demands of ...

Ayodeji Adegunsoye, MD, PhD, MSc, highlights how the underrepresentation of minority populations in pulmonary fibrosis genetic studies hinders accurate disease risk prediction and broader clinical ...

Medicine, Society and Culture (MSC) students participate in one 10-week clinical rotation each semester, averaging at least eight hours per week of direct experience and observation. Students will ...